Soft tissue reactions to bioactive glass 13-93 combined with chitosan

Journal of Biomedical Materials Research - Part A

Volumn 83, Issue 2, 2007, Pages 530-537

  Asikainen, A J ^a,b   Hagstrom J ^c   Sorsa, T ^a,c   Noponen, J ^a   Kellomaki M ^b   Juuti, H ^b   Lindqvist, C ^a,c   Hietanen, J ^a,c   Suuronen, R ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bioactive glass 13 93; Chitosan; MMP; TIMP

Indexed keywords

CHITOSAN; EOSINOPHILIC GRANULOCYTES; IMMUNOHISTOCHEMICAL ANALYSIS; MATRIX METALLOPROTEINASE (MMP);

ALLERGIES; BIOMEDICAL ENGINEERING; TISSUE;

BIOACTIVE GLASS;

BIOACTIVE GLASS 13 93; CHITOSAN; COLLAGENASE 3; GELATINASE A; GLASS; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EOSINOPHIL; EOSINOPHILIC GRANULOMA; FEMALE; FOLLOW UP; FOREIGN BODY GRANULOMA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROSTHESIS MATERIAL; RABBIT; SOFT TISSUE; SUBCUTANEOUS TISSUE; TISSUE REACTION;

ANIMALS; CHITOSAN; ENDOTHELIAL CELLS; FEMALE; FOREIGN-BODY REACTION; GLASS; IMMUNOHISTOCHEMISTRY; MATERIALS TESTING; MATRIX METALLOPROTEINASE 13; PROSTHESIS IMPLANTATION; RABBITS; SKIN;

EID: 35048873836     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31225     Document Type: Article

References (40)

1. St. John TA, Vaccaro AR, Sah AP, Schaefer M, Berta SC, Albert T, Hilibrand A. Physical and monetary costs associated with autogenous bone graft harvesting. Am J Orthop 2003;32:18-23.
2. Rikli DA, Regazzoni P, Perren SM. Is there a need for resorbable implants or bone substitutes? Injury 2002;33 (Suppl 2):B2-B3.
3. Howell SJ, Sear YM, Yeates D, Goldacre M, Sear JW, Foex P. Risk factors for cardiovascular death after elective surgery under general anaesthesia. Br J Anaesth 1998;80:14-19.
4. Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL, Gunsolley JC. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review. Ann Periodontol 2003;8:227-265.
5. Vesala AL, Kallioinen M, Törmälä P, Kellomäki M, Waris T, Ashammakhi N. Bone tissue engineering: treatment of cranial bone defects in rabbits using self-reinforced poly-L,D-lactide 96/4 sheets. J Craniofac Surg 2002;13:607-613.
6. Wilson J, Yli-Urpo A, Happonen RP.Bioactive glasses: Clinical applications. In: Hench L, Wilson J, editors. An Introduction to Bioceramics. Singapore:World Scientific; 1993. pp 63-73.
7. Clark AE, Hench LL, Paschall HA. The influence of surface chemistry on implant interface histology: a theoretical basis for implant materials selection. J Biomed Mater Res 1976;10:161-174.
8. Greenlee TK, Jr., Beckham CA, Crebo AR, Malmorg JC. Glass ceramic bone implants. J Biomed Mater Res 1972;6:235-244.
9. Hench LL, Paschall HA. Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. J Biomed Mater Res 1973;7:25-42.
10. Ruuttila P, Niiranen H, Kellomaki M, Tormala P, Konttinen YT, Hukkanen M. Characterization of human primary osteoblast response on bioactive glass (BaG 13-93)- coated poly-L,DL-lactide (SR-PLA70) surface in vitro. J Biomed Mater Res B Appl Biomater 2005;78:97-104.
11. Brink M. Bioactive glasses with a Large Working Range. Turku: Åbo Akademi University; 1997. 44p.
12. 2. J Biomed Mater Res 1997;37:114-121.
13. Gao T, Aro HT, Ylänen H, Vuorio E. Silica-based bioactive glasses modulate expression of bone morphogenetic protein-2 mRNA in Saos-2 osteoblasts in vitro. Biomaterials 2001;22:1475-1483.
14. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000;276:461-465.
15. Hench L. Bioceramics. J Am Ceram Soc 1998;81:1705-1728.
16. Ducheyne P, Qiu Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999;20:2287-2303.
17. Itälä A, Koort J, Ylänen HO, Hupa M, Aro HT. Biologic significance of surface microroughing in bone incorporation of porous bioactive glass implants. J Biomed Mater Res A 2003;67:496-503.
18. Karlsson KH, Fröberg K, Ringbom T. A structural approach to bone adhering of bioactive glasses. J. Non-Cryst Solids 1989;112:69-72.
19. Hench LL.Bioactive glasses and glass-ceramics: A perspective. In: Yamamuro T, Hench LL, Wilson J, editors. Handbook of Bioactive Ceramics: Bioactive Glasses and Glass-Ceramics. Boca Raton, FL: CRC Press; 1990. pp 7-23.
20. Malette WG, Quigley HJ, Gaines RD, Johnson ND, Rainer WG. Chitosan: a new hemostatic. Ann Thorac Surg 1983;36:55-58.
21. Klokkevold PR, Subar P, Fukayama H, Bertolami CN. Effect of chitosan on lingual hemostasis in rabbits with platelet dysfunction induced by epoprostenol. J Oral Maxillofac Surg 1992;50:41-45.
22. Ravi Kumar MNV. A review of chitin and chitosan applications. React Funct Polym 2000;46:1-27.
23. Choi HR, Kondo S, Hirose K, Ishiguro N, Hasegawa Y, Iwata H. Expression and enzymatic activity of MMP-2 during healing process of the acute supraspinatus tendon tear in rabbits. J Orthop Res 2002;20:927-933.
24. Brink M, Karlsson K, Yli-Urpo A. Novel bioactive glasses and their use. Finland patent FI 101129 B, 1998.
25. Brink M, Yli-Urpo S, Yli-Urpo A. The resorption of a bioactive glass implanted into rat soft tissue. Transactions of the Fifth World Biomaterials Congress, Toronto 1996:48.
26. 3 system. J Mater Sci: Mater Med 1990;1:219-227.
27. Brink M, Söderling E, Turunen T, Karlsson KH.Protein adsorption properties of bioactive glasses compared to their behavior in rabbit tibia. In: Wilson J, Hench LL, Greenspan D, editors. Bioceramics. Oxford: Elsevier Science; 1995. pp 471-476.
28. Kähäri VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999;31:34-45.
29. Uitto VJ, Overall CM, McCulloch C. Proteolytic host cell enzymes in gingival crevice fluid. Periodontol 2000. 2003;31:77-104.
30. Meikle MC, Bord S, Hembry RM, Compston J, Croucher PI, Reynolds JJ. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J Cell Sci 1992;103 (Pt 4):1093-1099.
31. Rifas L, Halstead LR, Peck WA, Avioli LV, Welgus HG. Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products. J Clin Invest 1989;84:686-694.
32. Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 1994;124:1091-1102.
33. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516.
34. Mori T, Murakami M, Okumura M, Kadosawa T, Uede T, Fujinaga T. Mechanism of macrophage activation by chitin derivatives. J Vet Med Sci 2005;67:51-56.
35. Domard A, Domard M. Chitosan: Structure-properties relationship and biomedical applications. In: Dumitriu S, editor. Polymeric Biomaterials, 2nd ed. New York: Marcel Dekker; 2001. pp 187-212.
36. Chellat F, Grandjean-Laquerriere A, Le Naour R, Fernandes J, Yahia L, Guenounou M, Laurent-Maquin D. Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles. Biomaterials 2005;26:961-970.
37. Sobue T, Hakeda Y, Kobayashi Y, Hayakawa H, Yamashita K, Aoki T, Kumegawa M, Noguchi T, Hayakawa T. Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts. J Bone Miner Res 2001;16:2205-2214.
38. Shibutani T, Yamashita K, Aoki T, Iwayama Y, Nishikawa T, Hayakawa T. Tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) stimulate osteoclastic bone resorption. J Bone Miner Metab 1999;17:245-251.
39. Asikainen AJ, Noponen J, Mesimäki K, Laitinen O, Peltola J, Pelto M, Kellomäki M, Ashammakhi N, Lindqvist C, Suuronen R. Tyrosine derived polycarbonate membrane is useful for guided bone regeneration in rabbit mandibular defects. J Mater Sci: Mater Med 2005;16:753-758.
40. Seol YJ, Lee JY, Park YJ, Lee YM, Young K, Rhyu IC, Lee SJ, Han SB, Chung CP. Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnol Lett 2004;26:1037-1041.